From Casetext: Smarter Legal Research

Aiken v. Bristol-Myers Squibb Co.

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION
Mar 14, 2013
No. C 12-05208 RS (N.D. Cal. Mar. 14, 2013)

Opinion

No. C 12-05208 RS

03-14-2013

JAMES T. AIKEN, et al., Plaintiffs, v. BRISTOL-MYERS SQUIBB COMPANY, MCKESSON CORPORATION, and DOES 1-100, Defendants v. JONATHAN KESSLER et al.,


ORDER GRANTING MOTION TO

STAY

Defendants move to stay proceedings pending transfer to the Plavix MDL or, in the alternative, pending a decision by Judge Chen to relate this action to the other Plavix actions in this District. Plaintiffs oppose any stay of this matter, arguing it will inconvenience plaintiffs and impede the efficient administration of justice. Further, they assert the MDL Court, in its initial order denying transfer of the action, indicated it wants this Court to rule on the pending motion to remand before the panel considers any further transfer motion.

On February 12, 2013, the MDL Court issued an order denying transfer of those matters on Schedule B, as they present the "unusual dilemma" of having been removed on multiple grounds, "including that they are 'mass actions' under the Class Action Fairness Act (CAFA)." Opening B. Ex. B and Opposition B. Ex. 3. Following this Order, defendants moved to withdraw CAFA as a grounds for removal. Subsequently, on February 20, 2013, the MDL panel issued an order conditionally granting transfer for those matters that had earlier been denied transfer. Opening B. Ex. C.

Courts in this and other jurisdictions regularly stay actions pending transfer to an MDL, including actions with motions to remand pending. See, e.g., Scroggins v. Hoffman-La Roche, Inc., No. C 12-2615 SI, 2012 WL 29006574 (N.D. Cal. July 16, 2012) (staying litigation pending transfer to Accutane MDL in the "interest of judicial economy and consistency" while a motion to remand was pending); In re Vioxx Prods. Liab. Litig., 360 F.Supp.2d 1352, 1354 (J.P.M.L. 2005) ("The pendency of a motion to remand to state court is not a sufficient basis to avoid inclusion in Section 1407 proceedings."); In re Prudential Ins. Co. of Am. Sales Practices Litig., 170 F.Supp.2d 1346, 1347 (J.P.M.L. 2001) (ordering transfer over plaintiff's objection as "remand motions can be presented to and decided by the transferee judge.").

A stay in this case will promote uniform decisions on important, recurring issues. See Kinney v. Bristol-Myers Squibb Co., No 12-4477 EMC (N.D. Cal. Dec. 3, 2012); Belinda v. Bristol-Myers Squibb Co., No. 12-5941 YGR (N.D. Cal. Jan 22, 2013). A stay will not prejudice plaintiffs, as they can reassert their motion to remand with the MDL Court, should it be transferred. Further, the MDL Court made clear its concern with transfer was not the pending motions to remand themselves, but the role that CAFA played in removal of this action from state court. As CAFA has been revoked as a grounds for removal, this concern is no longer at issue. Accordingly, this matter shall be stayed pending a decision by the MDL Court to transfer this case. The clerk is instructed to vacate all currently calendared dates.

IT IS SO ORDERED.

______________________

RICHARD SEEBORG

UNITED STATES DISTRICT JUDGE


Summaries of

Aiken v. Bristol-Myers Squibb Co.

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION
Mar 14, 2013
No. C 12-05208 RS (N.D. Cal. Mar. 14, 2013)
Case details for

Aiken v. Bristol-Myers Squibb Co.

Case Details

Full title:JAMES T. AIKEN, et al., Plaintiffs, v. BRISTOL-MYERS SQUIBB COMPANY…

Court:UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION

Date published: Mar 14, 2013

Citations

No. C 12-05208 RS (N.D. Cal. Mar. 14, 2013)

Citing Cases

Yuan v. Lewey

Since the establishment of the Plavix® MDL, both the undersigned judge and Judge Chen have ordered a stay of…

Gibson v. Bristol-Myers Squibb Co.

Other courts in this District that have granted motions to stay in similar cases. See Arenberg v.…